Intralobular zonal heterogeneity and hepatic indicator dilution curves

Z S Cai1, B A Luxon, E L Forker

  • 1Department of Physiology, School of Medicine, University of Missouri-Columbia 65212.

Summary

This study examines how zonal differences in liver structure affect the interpretation of hepatic indicator dilution curves. Traditional methods assume uniform function across all hepatocytes, but this may not hold true when there are variations in surface-to-volume ratios or permeability. The researchers developed a model to compare true and apparent rate constants for various solutes. They found that when permeability varies across zones, the errors in rate constant estimates can be significant. These errors may be both quantitative and qualitative, and the presence of heterogeneity is not detectable from outflow curves alone. The study highlights the need for revised methods to improve the accuracy of liver function assessments.

Frequently Asked Questions

Related Concept Videos

Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...